A third vaccine for COVID-19 has been registered in Cuba. Photo: Karolina Grabowska, Pexels
The Center for Genetic Engineering and Biotechnology (CIGB) presented the required documentation to the regulatory authority for Drugs, Equipment and Medical Devices (CECMED) on October 31st for its third vaccine against COVID-19.
According to the national TV news, the second technical meeting took place where the representatives of the CIGB presented the documentation. If it is approved, the CIGB can begin Phases I, II and III clinical trials of the COVID vaccine.
Clinical trials of Soberana I, the first Cuban vaccine against COVID-19, have had satisfactory results, without adverse or serious reactions. However, it is still necessary to determine the level of antibodies that the vaccine generates in volunteers.
Once the specialists have evaluated the new vaccination compound, a meeting will be held to discuss the results.
Each lot of vaccine manufactured or imported has to pass the evaluation process. Once it is ready, its use is authorized by means of a certificate.
David Urra is the chief marketing analyst at International Consulting & Representation Services/Cuba (IcarusCuba). He has produced market studies for a wide range of Latin American, European and U.S. clients exploring market entry possibilities in Cuba’s IT, tourism, ranching, pharmaceutical and manufacturing sectors.
In a move with both economic and geopolitical significance, Cuba has officially joined the New…
Cuba’s tourism sector, long a vital part of the island’s economy, is experiencing mixed fortunes…
Cuba took center stage at the 17th BRICS 2025 in Rio de Janeiro this weekend,…
Cuba has confirmed the 41st edition of the Havana International Fair (FIHAV 2025) will take…
WestJet CEO Alexis von Hoensbroech met Wednesday with Cuban President Miguel Díaz-Canel in Havana, a high-level meeting…
Cuba is ramping up efforts to address energy shortages through the expansion of photovoltaic solar…